✦ LIBER ✦

P.02.21 SAFETY OF INFLIXIMAB INFUSIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A 10 YEARS REAL-LIFE EXPERIENCE FROM A SINGLE CENTRE

✍ Scribed by Grossi, L.; Di Tullio, A.M.; Pagliaro, M.; Tavani, R.; Cocciolillo, S.; Ferri, O.; Ciccaglione, A.F.; Marzio, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety profile of infliximab in inflamma

✍ A. Armuzzi; L. Guidi; B. De Pascalis; I. Roberto; A. Lupascu; I. De Vitis; A. Pa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 373 KB

P220 Recombinant human erythropoietin in

✍ K.H. Katsanos; A. Tatsioni; D.E. Sigounas; P. Manousou; D. Chatzidis; D. Natsi; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

CO31 EFFICACY AND SAFETY OF INFLIXIMAB (

✍ M. Gasparetto; F. Vallortigara; L. Visonà Dalla Pozza; C. Mescoli; M. Cananzi; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P1155 SAFETY AND EFFICACY OF PEG-IFNa2a

✍ Casu, S.; Balestrieri, C.; Figorilli, F.; Onali, S.; Serra, G.; Chessa, L.; Lai, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P377 Safety profile and discontinuation

✍ Sharma, M.; Al Kaabi, S.; Al Dweik, N.; John, A.; Wani, H.; Al Ejji, K.; Al Moha 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB